NorthWest Biotherapeutics Inc (NWBO)

[VikingInvest]

$50M Revenue would be roughly equal to 250 patients through UK Compassionate use program (Not sure what the exact UK term is, but equal to what would have been termed compassionate use in US), if the $200k number that has been floated around here is the right price for the patients. That doesn't sound unreasonable to me. As the trial has progressed and the blinded results have looked amazing, it is likely that LL and Dr. Ashkan has been receiving inquiries from fellow doctors and have told them about the potential for their patients. As it is cost prohibitive for a lot of people, most have probably not been able to afford it, but a 250 number doesn't seem out of line.

I understand that company have not been forthcoming in regards to earnings calls in the past, but if a significant increase in revenue due to an influx of patients not in the trial is correct, maybe we will see one this week, hopefully in connection with a PR on TLD (The old 2 barrel). If not maybe next quarter, as I assume that there previously haven't been significant income to discuss.